Literature DB >> 9925786

Crystal structure of the E166A mutant of extended-spectrum beta-lactamase Toho-1 at 1.8 A resolution.

A Ibuka1, A Taguchi, M Ishiguro, S Fushinobu, Y Ishii, S Kamitori, K Okuyama, K Yamaguchi, M Konno, H Matsuzawa.   

Abstract

Bacterial resistance to beta-lactams is mainly due to the production of beta-lactamase. Especially through the production of extended-spectrum beta-lactamases (ESBLs), bacteria have acquired resistance not only to penicillins, but also to expanded-spectrum cephems. Here, we describe the crystal structure of the E166A mutant of class A beta-lactamase Toho-1 at 1.8 A resolution, the first reported tertiary structure of an ESBL. Instead of the wild-type enzyme, a mutant Toho-1, in which Glu166 was replaced with alanine, was used for this study, because of the strong tendency of the wild-type enzyme to form twinned crystals. The overall structure of Toho-1 is similar to the crystal structures of non-ESBLs, with no pronounced backbone rearrangement of the framework. However, there are some notable local changes. First, a difference in the disposition of an arginine residue, which is at position 244 in non-ESBLs but at position 276 in Toho-1 and other ESBLs, was revealed and the role of this arginine residue is discussed. Moreover, changes in the hydrogen-bonding pattern and in the formation of the hydrophobic core were also observed near the Omega loop. In particular, the lack of hydrogen bonds in the vicinity of the Omega loop could be a cause of the extended substrate specificity of Toho-1. Through the generation of a model for the enzyme-substrate complex, a conformational change of Toho-1 occurring on complex formation is discussed based on the active-site cleft structure and the substrate profile. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9925786     DOI: 10.1006/jmbi.1998.2432

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  36 in total

1.  Nucleotide sequence and characterization of a novel cefotaxime-hydrolyzing beta-lactamase (CTX-M-10) isolated in Spain.

Authors:  A Oliver; J C Pérez-Díaz; T M Coque; F Baquero; R Cantón
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

2.  A new SHV-derived extended-spectrum beta-lactamase (SHV-24) that hydrolyzes ceftazidime through a single-amino-acid substitution (D179G) in the -loop.

Authors:  H Kurokawa; T Yagi; N Shibata; K Shibayama; K Kamachi; Y Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

3.  Analysis of the bla(toho) gene coding for Toho-2-beta-lactamase.

Authors:  R Labia
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

4.  Characterization of a chromosomally encoded extended-spectrum class A beta-lactamase from Kluyvera cryocrescens.

Authors:  J W Decousser; L Poirel; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

Review 5.  Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat.

Authors:  P A Bradford
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

6.  Identification of a chromosome-borne expanded-spectrum class a beta-lactamase from Erwinia persicina.

Authors:  Sophie Vimont; Laurent Poirel; Thierry Naas; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

Review 7.  Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes.

Authors:  R Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

8.  Effects of Ser130Gly and Asp240Lys substitutions in extended-spectrum beta-lactamase CTX-M-9.

Authors:  C Aumeran; C Chanal; R Labia; D Sirot; J Sirot; R Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

9.  Roles of residues Cys69, Asn104, Phe160, Gly232, Ser237, and Asp240 in extended-spectrum beta-lactamase Toho-1.

Authors:  Akiko Shimizu-Ibuka; Mika Oishi; Shoko Yamada; Yoshikazu Ishii; Kiyoshi Mura; Hiroshi Sakai; Hiroshi Matsuzawa
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

10.  Biochemical-genetic analysis and distribution of DES-1, an Ambler class A extended-spectrum beta-lactamase from Desulfovibrio desulfuricans.

Authors:  Anne-Sophie Morin; Laurent Poirel; Francine Mory; Roger Labia; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.